GENEVA, June 19 -- PHARMAESSENTIA CORPORATION filed a patent application (IB2024/000812) for “ANTI-PD-1 MONOCLONAL ANTIBODY AND METHODS OF USE THEREOF”. With publication no. WO/2025/128264, here are the other details related to the patent application:
Kind: Corrected version of pamphlet [A9]
IPC: A61K 39/395
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....